ZOM

 

STOCK -FILL THE SHORT TABLE

ID	STOCK	REMARK PRICE	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
281	ZOM		RH	$0.90	798	$718.20	10000	$0.32	$3,183.00	$3,901.20	10798	$0.36	0

STOCK -FILL THE SHORT TABLE

ID	STOCK	REMARK PRICE	Field3	PRICES	AMOUNT	Field1	number	fill prices	fill dollar	total filled	total unit	average	NET LOSS	Field2	REMARK
174	ZOM	DOWN LOWEST AT 0.1722 (12/02/2020)	RH	$0.19	1000	$189.00	1000	$0.13	$130.00	$319.00	2000	$0.16	0	GAP 0.3
238	ZOM		RH	$0.18	1200	$221.28	1000	$0.15	$151.70	$372.98	2200	$0.17	0
281	ZOM		RH	$0.90	798	$718.20	5000	$0.32	$1,591.50	$2,309.70	5798	$0.40	0

12 ITstock moving

 12:55p ET 3/10/2022 - Benzinga

12 Information Technology Stocks Moving In Thursday's Intraday Session

Mentioned:

ACMR ASAN BASE CISO CRWDEBIX FOUR GDS JKS LIDR VNETXELA

Gainers

• Ebix (NASDAQ:EBIX) shares rose 27.1% to $40.55 during Thursday's regular session. Trading volume for Ebix's stock is 2.4 million as of 12:30 EST. This is 862.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion. As per the news, the Q4 earnings report came out yesterday.
• CrowdStrike Holdings (NASDAQ:CRWD) shares rose 14.27% to $194.02. CrowdStrike Holdings's stock is trading at a volume of 16.1 million shares as of 12:30 EST. This is 369.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $44.4 billion. As per the press release, Q4 earnings came out yesterday.
• Exela Technologies (NASDAQ:XELA) stock rose 14.27% to $0.88. Exela Technologies's stock is trading at a volume of 35.0 million shares as of 12:30 EST. This is 94.9% of its average full-day volume over the last 100 days. The company's market cap stands at $306.8 million.
• Cerberus Cyber Sentinel (NASDAQ:CISO) shares moved upwards by 13.79% to $5.6. As of 12:30 EST, Cerberus Cyber Sentinel's stock is trading at a volume of 326.4K, which is 45.6% of its average full-day volume over the last 100 days. The company's market cap stands at $753.9 million.
• AEye (NASDAQ:LIDR) shares rose 10.35% to $4.0. Trading volume for this security as of 12:30 EST is 356.8K, which is 52.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $621.7 million.
• Shift4 Payments (NYSE:FOUR) shares rose 7.71% to $49.3. As of 12:30 EST, Shift4 Payments's stock is trading at a volume of 1.0 million, which is 80.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 billion.

Losers

• ACM Research (NASDAQ:ACMR) shares fell 26.8% to $59.95 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 635.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion.
• Asana (NYSE:ASAN) stock decreased by 24.15% to $37.02. The current volume of 14.6 million shares is 325.9% of Asana's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $7.0 billion. As per the news, the Q4 earnings report came out yesterday.
• JinkoSolar Holding Co (NYSE:JKS) shares fell 18.76% to $46.31. JinkoSolar Holding Co's stock is trading at a volume of 2.8 million shares as of 12:30 EST. This is 236.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.2 billion.
• VNET Group (NASDAQ:VNET) stock fell 17.34% to $5.61. The current volume of 1.6 million shares is 63.8% of VNET Group's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $832.0 million.
• GDS Holdings (NASDAQ:GDS) shares fell 16.06% to $34.16. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 95.8% of its average full-day volume over the last 100 days. The company's market cap stands at $6.5 billion.
• Couchbase (NASDAQ:BASE) stock declined by 14.77% to $15.82. Couchbase's stock is trading at a volume of 887.6K shares as of 12:30 EST. This is 154.0% of its average full-day volume over the last 100 days. The company's market cap stands at $689.6 million. As per the news, the Q4 earnings report came out yesterday. See Also:www.benzinga.com/money/tech-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

PIE # 3 exercise

SoNim

Sonim up today 08 March 2022

 Sonim and AdvanceTec Introduce 'Made in the U.S.' Accessories for Rugged XP3plus Phone

Mentioned:

SONM

Sonim Technologies (Nasdaq: SONM) and AdvanceTec Industries have teamed up to launch a broad portfolio of made in the U.S. products, including handsfree accessories, multi-bay chargers, battery chargers, headsets and remote speaker microphones.

https://mma.prnewswire.com/media/1748663/Sonim_Technologies_Inc_XP3Plus_CarKit_3.jpg

AdvanceTec manufactures Sonim compatible products from its 30,000 square-foot facility in Miami. This facility includes product development, tool and mold making, plastic injection molding, and high-speed surface mount equipment. AdvanceTec's control of its supply chain and manufacturing has allowed it to avoid most of the pains associated with the pandemic and the global supply chain crisis.

"AdvanceTec was able to deliver multi-bays within two weeks to a major Sonim client to allow for a seamless transition from land mobile radios to Sonim phones, and avoid deployment delays," said John Graff, Sonim Chief Marketing Officer. "Our rugged flip phone is Sonim's highest volume product, and the complete accessory offering for the XP3plus from AdvanceTec helps accelerate rugged mobility deployments in a wide variety of applications."

AdvanceTec offers the broadest portfolio of U.S.-made XP3plus accessories, including:

-- A handsfree vehicle kit that improves sound quality, driver safety, and is the perfect companion for Push-to-Talk (PTT) communications. The vehicle kit consists of a junction box, 10 watt external speaker, remote PTT button, noise cancelling visor microphone and a power cable.

-- An affordable cradle with power to securely hold the XP3plus in vehicle, while providing continuous power.

-- A heavy-duty aluminum construction six bay charger that powers six XP3plus phones at 2.0A each, allowing for organized and reliable drop-in power.

For more information, visit Sonim Accessories.

About Sonim Sonim Technologies is a leading U.S. provider of ultra-rugged mobility solutions designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The Sonim solution includes ultra-rugged mobile phones, a suite of industrial-grade accessories, and data and workflow applications which are collectively designed to increase worker productivity, communication and safety on the job site. Please visit https://sonimtech.com/.

Important Cautions Regarding Forward-Looking StatementsThis release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, future performance of Sonim's and its partners' devices and technologies and continued market acceptance of same. These forward-looking statements are based on Sonim's current expectations, estimates and projections about its business and industry, management's beliefs and certain assumptions made by the Company, all of which are subject to change. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For a listing of factors that may cause actual results to differ materially, see the potential factors described under "Risk Factors" included in Form 10-K for the year ended December 31, 2020, and other documents on file with the Securities and Exchange Commission (available at www.sec.gov). Sonim cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Sonim assumes no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, except as required by law.

https://mma.prnewswire.com/media/151907/sonim_technologies_logo.jpg

https://c212.net/c/img/favicon.png?sn=SF65391&sd=2022-02-17

View original content to download multimedia:https://www.prnewswire.com/news-releases/sonim-and-advancetec-introduce-made-in-the-us-accessories-for-rugged-xp3plus-phone-301484835.html

SOURCE Sonim Technologies, Inc.

https://rt.prnewswire.com/rt.gif?NewsItemId=SF65391&Transmission_Id=202202170900PR_NEWS_USPR_____SF65391&DateId=20220217

COMTEX_402587087/1005/2022-02-17T09:00:58

BCEL

News, March 04, 2022
4:38 pm ET	12 Health Care Stocks Moving In Friday's After-Market Session(Benzinga)
3:59 pm ET	*Atreca Shares Spike To Over $5 Level, Now Up 200% For Session(Benzinga)
3:54 pm ET	*Atreca Shares Spike To Session High, Upside Intensifies Sharply Over Last Few Mins; Shares Up 135% For Session Near $4 Level(Benzinga)
3:52 pm ET	Atreca, Inc. CEO John Orwin on Q4 2021 Results -- Earnings Call Transcript >BCEL(Dow Jones)
1:08 pm ET	*Atreca shares are trading higher after the company reported Q4 earnings results and updated investors on its ongoing ATRC-101 Phase 1b trial.(Benzinga)
1:01 pm ET	12 Health Care Stocks Moving In Friday's Intraday Session(Benzinga)
8:30 am ET	Atreca to Participate in Cowen 42nd Annual Healthcare Conference(Globe Newswire)
6:40 am ET	Atreca stock price target cut to $14 from $17 at Stifel Nicolaus(MarketWatch)
March 03, 2022

 

CSCW

 NEW YORK, Feb. 14, 2022/PRNewswire/ -- Color Star Technology Co., Ltd. (NASDAQ: CSCW) (hereinafter referred to as "Color Star" or the "Company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence ("AI") in the entertainment industry, announced today that a localized Asian version of its entertainment metaverse Color World will be released this month.

Since the release of the entertainment metaverse Color World on the iOS store, the app developed by Color Star has been downloaded by more than one million users. As the current version is only available in English, Color Star will be releasing a localized Asian version in order to allow users in Asia to experience and access the metaverse app as well. The Asian version will be available in simplified and traditional Chinese, Japanese and Korean. Furthermore, in-app content will mainly feature Asian celebrities, Asian music, Asian folk instrument masterclasses, occasional virtual celebrity meet-ups and concerts with Asian celebrities.

The Asian version will be available on both the Apple and Android app stores, and users in Asia can download Color World directly from their region's app store. At present, the development team is updating the app regularly with improvements and new features, hoping to provide an even better user experience for users around the world. Soon, users will be greeted by two new in-game areas: a dedicated gaming zone and an entertainment zone.

About Color Star Technology

Color Star Technology Co, Ltd. (Nasdaq: CSCW) is an entertainment and education company that provides online entertainment performances and online music education services. Its business operations are conducted through its wholly-owned subsidiaries, Color China Entertainment Ltd. and CACM Group NY, Inc. The Company's online education is provided through its Color World music and entertainment education platform. More information about the Company can be found at www.colorstarinternational.com.

Forward-Looking Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantee of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development, including the development of the metaverse project; product and service demand and acceptance; changes in technology; economic conditions; the growth of the educational and training services market internationally where CSCW conducts its business; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof unless required by applicable laws, regulations or rules.

NOK

 

SOS

 Sell off SOS on 02/16/2022 (Wednesday) -21share sell at 0.90 

TD  stock my avarage 0.9886 current price 0.87 as of 10:19am to get in again on monday and friday

buy back event 9:10 to 9:20     1.79M purchase         0.7905-0.8698 

buy  back event 9:30 to 9:40     3.61M purchase     0.84-0.9295

buy back event  9:40 to 9:50     3.59M purchase 0.91-0.96 

and then was down to 0.8921 

 

 

market open at 0.715

low at 0.7011

high at 0.96

SOS getting in as of 02/16/2022

 

UTSI

 

ARDX

https://www.msn.com/en-us/money/watchlist?tab=Related&id=a1np1h&ocid=ansMSNMoney11&duration=1D&relatedQuoteId=a1np1h&relatedSource=MlAl

 

ONCY

Yeh

 

Updating the market on its flagship immunotherapeutic agent pelareorep, Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) laid out its primary breast cancer achievements in 2021, as well as its 2022 program to come in its latest letter to shareholders.

For breast cancer patients treated with pelareorep Oncolytics has witnessed a more-than-doubling of overall survival in metastatic HR+/HER2- in IND-213--as seen from study results delivered in 2017.

Through a series of data analysis, Oncolytics chose to focus on the three achievable objectives put in place by regulators and the company's pharma partners, representing important steps towards a registrational study. This included: 1. Confirming that pelareorep works through an immunotherapeutic mechanism of action; 2. Determining whether pelareorep synergizes with immune checkpoint inhibitors; and 3. Identifying a biomarker to select patients who are likely to have better clinical outcomes.

In the shareholders letter, Dr. Matt Coffey, President & CEO of Oncolytics Biotech, wrote: "I am pleased to report that we are well on our way to achieving these three objectives."

Back in April 2021, Oncolytics presented cohort data from its AWARE-1 study, being conducted with Roche, showing that the first two objectives referenced above had been achieved.

By December at the 2021 San Antonio Breast Cancer Symposium (SABCS), Oncolytics presented a positive safety update from its IRENE Phase 2 Triple-Negative Breast Cancer Trial evaluating the safety and efficacy of pelareorep in combination with the anti-PD-1 checkpoint inhibitor retifanlimab from Incyte for second- or third-line treatment of patients with metastatic triple-negative breast cancer (TNBC).

"Prior clinical studies have shown that pelareorep upregulates tumor PD-L1 expression and reverses immunosuppressive TMEs," said Mridula George, M.D., Medical Oncologist, Rutgers Cancer Institute of New Jersey, Assistant Professor of Medicine, Rutgers Robert Wood Johnson Medical School, and principal investigator of the trial. "These findings suggest that pelareorep can address a pressing unmet need in TNBC by synergizing with PD-1 inhibition to increase the proportion of patients responding to therapy. We look forward to evaluating this hypothesis through the IRENE study's continued advancement and are pleased that the pelareorep-retifanlimab combination has been well-tolerated in each of the patients enrolled in the trial."

Safety data from the trial showed the combination was well-tolerated, with no safety concerns noted in any of the patients enrolled in the trial at the time of reporting. The IRENE study remains ongoing and will continue to enroll patients at the Rutgers Cancer Institute of New Jersey and the Ohio State University Comprehensive Cancer Center.